---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-095776"
form_type: "8-K"
ticker: "CERO"
cik: "0001870404"
company_name: "CERO THERAPEUTICS HOLDINGS, INC."
filed_at: "2026-08-31T20:52:35+00:00"
generated_at: "2026-08-31T20:53:30.021137+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CERo Therapeutics secures up to $11.67M senior secured note with SRX Global

## Summary
- Consolidates prior notes of $5,666,108.77 (SRX $2,794,000; Keystone $2,872,108.77) plus up to $6M additional advances.
- Initial advance of $775,665 on Aug 27, 2026; proceeds for trade payables and working capital.
- 10% annual interest (24.99% on default); matures Oct 15, 2026; secured by subsidiary stock and all assets.
- Subsidiary CERo Therapeutics, Inc. guarantees payment; collateral includes IP, patents, CER-1236 assets.

## SEC filing metadata
- accession: 0001213900-26-095776
- form_type: 8-K
- ticker: CERO
- cik: 0001870404
- company_name: CERO THERAPEUTICS HOLDINGS, INC.
- filed_at: 2026-08-31T20:52:35+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870404/000121390026095776/0001213900-26-095776-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870404/000121390026095776/ea0304037-8k_cero.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-095776
- JSON: https://secwatch.observer/filing/0001213900-26-095776.json
- Plain text: https://secwatch.observer/filing/0001213900-26-095776.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.